Empire Energy Group (ASX:EEG) has commenced drilling for its Carpentaria Pilot Project in the Beetaloo Basin in the Northern Territory after receiving environmental clearance. The initiative aims to deliver much-needed gas to the Northern Territory and east coast markets, supported by local and federal government strategies.
Copyright 2024 – Finance News Network
Source: Finance News Network
10 Oct 2023 - Harry Fisher - Project Manager - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More01 Mar 2021 - RooLife Group Limited (ASX:RLG) CEO Bryan Carr talks about taking global brands into the Chinese market, targeting consumers directly via a range of platforms and e-commerce solutions.
Read More06 May 2020 - Acorn Capital Investment Fund Ltd. (ASX: ACQ) Head of Research and Portfolio Manager for the Consumer Discretionary, Consumer Staples and Information Technology sectors, Robert Bruce talks about the listed investment company, the fund’s composition and outlook for the next 6 months and longer term.
Read More01 Aug 2025 - AI platform revolutionising pharmaceutical quality control
Read More01 May 2023 - James Powell, General Manager - Investor Relations, Corporate Affairs and Sustainability of Rural Funds Management, provides on update for the Rural Funds Group (ASX:RFF).
Read More16 Aug 2021 - BluGlass Limited (ASX:BLG) Executive Chair, James Walker and Chief Technology and Operations Officer, Dr Ian Mann discuss the company’s world-first demonstration of working tunnel junction laser diodes created using remote plasma chemical vapour deposition (RPCVD) technology.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi’s blockbuster insomnia drug Ambien and focus for 2020.
Read More29 Sep 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Michael Baker discusses the company's collaboration with Imugene to combine therapies.
Read More
